Oxistat
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- Brand name
- Oxistat
- Generic name
- OXICONAZOLE NITRATE
- Manufacturer
- ANI Pharmaceuticals, Inc.
- Product type
- HUMAN PRESCRIPTION DRUG
- SPL set ID
- 64ef2286-0f56-4a8a-b07b-4a597f078ae0
- SPL ID
- 50797bb3-2b74-48ab-8619-0adb3ac33e15
- Version
- 6
- Effective date
- 2026-10-01
- Source export date
- 2026-11-13
- Source partition
- 10
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0010-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-11-13/829e43b83940afb8dda22d5287c5b17e57d3fe45d1157678854b4f9b7ad07271/drug-label-0010-of-0014.json.zip
- Source manifest SHA-256
- 8f2b6d063d44586cf97cedcdf1bdf9e261cc88632cc6855424b801bb206208d7
- Import run
- 20261116T150851Z
- Imported at
- 2026-11-16 17:15:17
| Harmonized routes |
|---|
| TOPICAL |
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| application applno | NDA | 020209 | derived:openfda.application_number |
| application number | NDA020209 | openfda.application_number | |
| brand name | Oxistat | openfda.brand_name | |
| generic name | OXICONAZOLE NITRATE | openfda.generic_name | |
| manufacturer name | ANI Pharmaceuticals, Inc. | openfda.manufacturer_name | |
| ndc | package | 62559-285-06 | openfda.package_ndc |
| ndc | package | 62559-285-60 | openfda.package_ndc |
| ndc | package | 62559-285-30 | openfda.package_ndc |
| ndc | product | 62559-285 | openfda.product_ndc |
| ndc11 | package | 62559028506 | derived:openfda.package_ndc |
| ndc11 | package | 62559028530 | derived:openfda.package_ndc |
| ndc11 | package | 62559028560 | derived:openfda.package_ndc |
| rxcui | 207249 | openfda.rxcui | |
| rxcui | 312140 | openfda.rxcui | |
| spl id | 50797bb3-2b74-48ab-8619-0adb3ac33e15 | id | |
| spl set id | 64ef2286-0f56-4a8a-b07b-4a597f078ae0 | set_id | |
| unii | RQ8UL4C17S | openfda.unii |
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
WARNINGS OXISTAT (oxiconazole nitrate) Lotion, 1% is for topical use only and not for oral, ophthalmic or intravaginal use.
Adverse reactions cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
adverse reactions
ADVERSE REACTIONS In a controlled, multicenter clinical trial of 269 patients treated with oxiconazole nitrate lotion , 1%, 7 (2.6%) reported adverse reactions thought to be related to drug therapy. These reactions included burning and stinging (0.7% each) and pruritus, scaling, tingling, pain, and dyshidrotic eczema (0.4% each). The following additional adverse experiences have been reported with the topical use of oxiconazole nitrate: irritation and allergic contact dermatitis, folliculitis, erythema, papules, fissure, maceration, rash, and nodules. To report SUSPECTED ADVERSE REACTIONS, contact ANI Pharmaceuticals, Inc. at 1-855-204-1431 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.